SS-31 2S50 50mg*10vials

SS-31 2S50 50mg*10 vials (Elamipretide) is the flagship fully saturated product in the entire SS-31 mitochondrial-targeted antioxidant peptide series, a top-tier upgrade surpassing the basic 2S10 and intermediate 2S20 specifications. As a patented cell-permeable endogenous tetrapeptide, it possesses unique and precise cardiolipin binding properties, achieving 1000 times higher mitochondrial selective accumulation, zero immunogenicity, and extremely high biochemical stability. Breaking through the efficacy saturation limit of traditional medium-dose SS-31 products, the industry's highest 50mg ultra-high fully saturated dose achieves complete saturation binding to cardiolipin in the mitochondrial inner membrane, thereby maximally stabilizing the respiratory chain supercomplex structure and eliminating severe oxidative stress damage at its source. It uniquely achieves ultimate mitochondrial reconstruction, full-load multi-organ damage repair, and ultra-deep anti-aging protection effects that low-dose and medium-dose formulations cannot reach. It is perfectly suited for modeling severe irreversible mitochondrial damage, intervening in ischemia-reperfusion injury, studying advanced neurodegenerative diseases and severe cardiovascular injuries, conducting ultra-high-intensity oxidative stress limit experiments, and validating ultra-complex peptide-assisted organ protection structures. It is a core, top-tier preclinical research material for cutting-edge research in mitochondrial pathophysiology and pharmacology of severe degenerative diseases.

Product Functions and Research Value

In ultra-high-intensity, extreme systemic laboratory studies, SS-31 2S50 50mg can trigger fully saturated cardiolipin binding and respiratory chain supercomplex locking, maximally stabilizing mitochondrial membrane potential and achieving ultimate reconstruction of mitochondrial function and resetting of energy metabolism. Its core research advantages encompass five key dimensions: fully saturated cardiolipin anchoring, fundamentally repairing damaged mitochondrial cristae structure; ultimate blocking of endogenous reactive oxygen species (ROS) sources, eliminating severe and persistent oxidative cascade damage; ultra-significant respiratory chain optimization, achieving peak ATP energy synthesis efficiency; complete inhibition of severe oxidative-induced apoptosis and irreversible tissue damage; and ultra-deep multi-organ mitochondrial protection, reversing late-stage degenerative aging. 2S50 50mg offers efficacy far exceeding the balanced moderate potency of 2S20, possessing instantaneous super-strong efficacy, long-lasting and non-attenuating full-load protection, and the ability to reverse irreversible severe mitochondrial damage. It uniquely intervenes in refractory severe mitochondrial damage, end-stage energy metabolic failure, advanced neuronal and cardiomyocyte degeneration, and extreme oxidative stress damage that are insensitive to conventional high-dose regimens. It can completely repair the disintegrated mitochondrial cristae structure, permanently stabilize membrane potential balance, completely block the explosive production of large amounts of reactive oxygen species (ROS), and maximize cellular energy cycle efficiency. Simultaneously, it has outstanding protective effects against myocardial ischemia-reperfusion injury, severe neurooxidative degeneration, and multi-organ mitochondrial dysfunction, fundamentally reversing the progression of end-stage degenerative pathologies. The flagship 50mg full-saturation specification perfectly meets the limits of ultra-limit dose threshold screening, end-stage severe mitochondrial damage modeling, advanced multi-organ degenerative disease intervention, and extreme validation of the synergistic effects of top-tier complex peptides, providing highly discriminative, authoritative, and reproducible data for cutting-edge research on extreme mitochondrial repair and organ anti-aging. Core Product Advantages

1. Ultimate Fully Saturated Mitochondrial Targeting: The top-tier 50mg ultra-high dose achieves 100% saturated cardiolipin binding, completely locking the stability of the mitochondrial inner membrane structure and respiratory chain supercomplex, breaking through the efficacy limits of all low-to-medium dose SS-31 specifications and reaching the pinnacle of mitochondrial repair capabilities in this series.

2. Source-Level Ultimate Antioxidant Protection Against Free Radicals: Possesses superior endogenous ROS burst inhibition and oxidative cascade free radical scavenging capabilities, reversing severe irreversible oxidative damage that conventional saturated doses cannot improve, representing the highest source-level antioxidant efficacy of SS-31 peptides.

3. Five-Dimensional Ultra-Ultimate Multi-Organ Repair Synergy: Integrates ultimate mitochondrial structure reconstruction, peak energy metabolism optimization, severe oxidative free radical scavenging, full-load anti-apoptosis protection, and ultra-deep advanced anti-degeneration efficacy, achieving comprehensive repair.